UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 9, 2003
STAAR SURGICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware 0-11634 95-3797439
(State or other jurisdiction) (Commission File Number) (I.R.S. Employer
of incorporation or organization) Identification No.)
1911 Walker Avenue, Monrovia, California 91016
(Address of principal executive offices) (Zip Code)
(626) 303-7902
(Registrant's telephone number, including area code)
The information furnished with this report will not be treated as
"filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that section. This information will not
be incorporated by reference into a filing under the Securities Act of 1933, or
into another filing under the Exchange Act, unless that filing expressly refers
to specific information in this report.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit Number Description
-------------- -----------
99.1 Press Release dated October 9, 2003.
99.2 Transcript of a conference call conducted by STAAR Surgical Company on
October 9, 2003.
Item 9. Regulation FD Disclosure.
On October 9, 2003, the Company conducted a conference call to discuss
the recommendation by the U.S. Food and Drug Administration Ophthalmic Devices
Panel of the Center for Devices and Radiological Health that the Company's
Implantable Contact Lens(TM) (ICL(C)), a phakic implant used to correct
refractive errors, be approved with conditions for use in correcting myopia in
the range of -3 diopters to -15 diopters and reducing myopia in the range of -15
diopters to -20 diopters. A transcript of the conference call is furnished with
this report as Exhibit 99.2 and is incorporated herein by this reference.
Item 12. Results of Operations and Financial Condition.
On October 9, 2003, the Company issued a press release announcing a
preliminary estimate of revenue for the third fiscal quarter of 2003. A copy of
the press release is attached as Exhibit 99.1 to this report and is incorporated
herein by this reference.
The preliminary estimate of revenue was also discussed in the October
9, 2003 conference call described under Item 9. That discussion is included in
the transcript of the call furnished with this report as Exhibit 99.2, and is
incorporated herein by this reference.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: October 10, 2003 STAAR SURGICAL COMPANY
By: /s/ John Bily
___________________
John Bily
Chief Financial Officer
-3-
Exhibit Index
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
99.1 Press Release dated October 9, 2003.
99.2 Transcript of a conference call conducted by STAAR Surgical Company on
October 9, 2002.
-4-